Silence Therapeutics plc (SLN): Total Assets
$131.44M
As of 2025-12-31
$106.41M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $131.44M | -35.1% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $202.63M | +69.6% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $119.45M | n/a | 2025-02-27, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Silence Therapeutics plc (SLN) | 2025-12-31 | $131.44M | -35.1% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $30.16M | -54.9% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $5.33M | -60.5% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $2.67M | -25.3% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $12.87M | +43.1% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $2.60M | -28.5% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $45.92M | -39.9% |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $44.92M | +17.2% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $390.0K | -96.1% |
Compare SLN, YARW, QUCY, LIPO side by side · Screen every company in Pharmaceutical Preparations ↗